A Study of Dulaglutide (LY2189265) in Participants With Type II Diabetes

Clinical trial NCT02152371 · COMPLETED

Trial details

NCT number: NCT02152371
Sponsor: Eli Lilly and Company
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Diabetes Mellitus, Type 2

Start date: 2014-05-01
Primary completion: 2015-10-01
Enrollment: 300

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.